Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · February 28, 2023

Association Between Fracture Risk and SGLT2 Inhibitors in Patients With Type 2 Diabetes Across eGFR and Albuminuria Categories

Diabetes Research and Clinical Practice


Additional Info

Disclosure statements are available on the authors' profiles:

Diabetes Research and Clinical Practice
Fracture risks associated with sodium-glucose cotransporter 2 inhibitors in type 2 diabetes patients across eGFR and albuminuria categories: a population-based study in Hong Kong
Diabetes Res. Clin. Pract. 2023 Feb 11;[EPub Ahead of Print], D Tak Wai Lui, T Wu, E Ho Man Tang, I Chi Ho Au, C Ho Lee, Y Cho Woo, K Choon Beng Tan, C King Ho Wong

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading